Repligen Corporation to Present at Wells Fargo Healthcare Conference
August 23, 2024 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be...
Repligen Reports Second Quarter 2024 Financial Results
July 30, 2024 07:30 ET
|
Repligen Corporation
Reports second quarter revenue of $154 millionSecond quarter orders of $157 millionBook-to-bill 1.02 for the quarter, 1.01 year-to-dateAchieved first half revenue and order targetsNarrows revenue...
Repligen Announces Agreement to Acquire Chromatography Innovator Tantti
July 29, 2024 16:00 ET
|
Repligen Corporation
Proposed acquisition adds novel macroporous chromatography base bead technology for downstream bioprocess applicationsAccelerates expansion into new modality markets with a unique, scalable...
Repligen to Report Second Quarter 2024 Financial Results
July 16, 2024 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its second quarter 2024 financial results on Tuesday, July 30, 2024....
Repligen Announces CEO Transition Plan
June 13, 2024 07:00 ET
|
Repligen Corporation
WALTHAM, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that its Board of...
Repligen Corporation to Present at Upcoming June Investor Conferences
May 22, 2024 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be...
Repligen Corporation to Present at Upcoming May Investor Conferences
May 07, 2024 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be...
Repligen Reports First Quarter 2024 Financial Results
May 01, 2024 07:30 ET
|
Repligen Corporation
Reports first quarter revenue of $151 million Increased new modalities revenue by 16% year-over-yearIncreased Filtration (non-COVID) revenue by 12% year-over-yearAchieved a nine-month book-to-bill...
Repligen to Report First Quarter 2024 Financial Results
April 17, 2024 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., April 17, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first quarter 2024 financial results on Wednesday, May 1, 2024....
Repligen Appoints Maggie A. Pax to Board of Directors
March 19, 2024 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced the appointment to its Board of Directors of life sciences industry executive Maggie A. Pax....